Breaking News Instant updates and real-time market news.

ACRX

AcelRx

$2.98

-0.075 (-2.46%)

07:40
07/13/18
07/13
07:40
07/13/18
07:40

AcelRx initiated with a Perform at Oppenheimer

Oppenheimer analyst Leland Gershell initiated AcelRx with a Perform rating, citing regulatory uncertainty and commercial headwinds. In a note to investors, Gershell says that he "lacks conviction" on Dsuvia and Zalviso's ability to take meaningful share within the large acute pain/injectable opioid treatment market and that he is "cautious" in the near-term on Dsuvia's late-2018 FDA decision in a regulatory and societal atmosphere attuned to opioids' liabilities.

  • 12

    Jul

ACRX AcelRx
$2.98

-0.075 (-2.46%)

06/12/18
CANT
06/12/18
INITIATION
CANT
Cantor expands Specialty Pharmaceuticals coverage with eight names
Cantor Fitzgerald analyst Brandon Folkes last night rolled out coverage on eight names in the Specialty Pharmaceuticals space. He initiated coverage of AcelRx (ACRX), ANI Pharmaceuticals (ANIP), Biohaven Pharmaceutical (BHVN), Collegium Pharmaceutical (COLL), Emergent BioSolutions (EBS), Eagle Pharmaceuticals (EGRX) and Opiant Pharmaceuticals (OPNT) with Overweight ratings. There is still value to be unlocked in these stocks at current valuations with risk/reward profiles that remain to the upside, Folkes told investors in a research note. His top picks are ANI Pharmaceuticals, Emergent BioSolutions and Collegium Pharmaceutical. The analyst rounded out his coverage with a Neutral rating on Momenta (MNTA), saying the recent share rally puts him on the sidelines "for now."
06/11/18
CANT
06/11/18
INITIATION
Target $6
CANT
Overweight
AcelRx initiated with an Overweight at Cantor Fitzgerald
Cantor initiated AcelRx with a Overweight and $6 price target.
10/27/17
HCWC
10/27/17
NO CHANGE
Target $5
HCWC
Buy
H.C. Wainwright still believes AcelRx's Dsuvia will be approved
H.C. Wainwright analyst Ed Arce says that respite the complete response letter from the FDA, he still believes AcelRx's Dsuvia will be approved. The analyst lowered his price target for the shares to $5 from $7 and keeps a Buy rating on the name. While not easy to get an opioid approved in this environment, Dsuvia has a "far wider therapeutic index" than any other opioid, the analyst contends.
10/13/17
JEFF
10/13/17
DOWNGRADE
Target $2.25
JEFF
Hold
AcelRx downgraded to Hold from Buy at Jefferies
Jefferies analyst Matthew Andrews downgraded AcelRx Pharmaceuticals to Hold saying a one year delay for Dsuvia seems likely after the FDA issued a complete response letter. The analyst cut his price target for the shares to $2.25 from $7.00. While the two key issues cited in the CRL appear addressable, the shares have a lack of key catalysts until mid-2018, Andrews tells investors in a research note.

TODAY'S FREE FLY STORIES

XERS

Xeris Pharmaceuticals

$18.26

-0.18 (-0.98%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Initiation
Xeris Pharmaceuticals initiated  »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INST

Instructure

$44.93

-0.225 (-0.50%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Initiation
Instructure initiated  »

Instructure initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 30

    Jul

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Hot Stocks
Bank of America CEO says solid operating leverage drove earnings in Q2 »

Brian Moynihan, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

USO

United States Oil Fund

$14.47

0.085 (0.59%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Technical Analysis
United States Oil Fund: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIIV

i3 Verticals

$16.73

-0.025 (-0.15%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Initiation
i3 Verticals initiated  »

i3 Verticals initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$17.14

0.08 (0.47%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Conference/Events
Krystal Biotech management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 25

    Jul

XOP

SPDR Oil Exploration and Production Fund

$43.19

0.06 (0.14%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Hot Stocks
Bank of America reports Q2 average loan balances in business segments up 5% »

Average loan balances in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$26.43

0.89 (3.48%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$102.95

0.17 (0.17%)

, TEVA

Teva

$23.29

-0.45 (-1.90%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Recommendations
Neurocrine, Teva analyst commentary  »

Neurocrine price target…

NBIX

Neurocrine

$102.95

0.17 (0.17%)

TEVA

Teva

$23.29

-0.45 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

  • 16

    Sep

UGAZ

VelocityShares 3x Long Natural Gas ETN

$54.61

-2.06 (-3.64%)

06:50
07/16/18
07/16
06:50
07/16/18
06:50
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:50
07/16/18
07/16
06:50
07/16/18
06:50
Hot Stocks
Bank of America reports Q2 NII up 6% to $11.7B »

Reflecting benefits from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

ERJ

Embraer

$21.50

-0.78 (-3.50%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Periodicals
Embraer sees demand for 10,550 smaller jets in next 20 years, Reuters reports »

Brazil's Embraer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

EPRT

Essential Properties Realty Trust

$14.00

(0.00%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Initiation
Essential Properties Realty Trust initiated  »

Essential Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$34.05

0.67 (2.01%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNTR

Venator Materials

$16.76

0.07 (0.42%)

, TROX

Tronox

$19.31

-0.28 (-1.43%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Hot Stocks
Venator Materials to acquire European paper laminates business from Tronox »

Venator Materials (VNTR)…

VNTR

Venator Materials

$16.76

0.07 (0.42%)

TROX

Tronox

$19.31

-0.28 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

PSA

Public Storage

$228.07

-1.43 (-0.62%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Downgrade
Public Storage rating change  »

Public Storage downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EFA

iShares MSCI EAFE Index Fund

$67.80

0.21 (0.31%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Hot Stocks
Bank of America reports Q2 return on average assets 1.17% »

Reports Q2 return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

BRO

Brown & Brown

$28.76

0.025 (0.09%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Hot Stocks
Brown & Brown subsidiary acquires Professional Disability Associates »

J. Scott Penny, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JNK

SPDR Barclays High Yield Bond

$35.69

(0.00%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$20.45

-0.11 (-0.54%)

06:47
07/16/18
07/16
06:47
07/16/18
06:47
Conference/Events
Intra-Cellular management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SJB

ProShares Short High Yield

$22.95

-0.055 (-0.24%)

06:47
07/16/18
07/16
06:47
07/16/18
06:47
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSUR

OraSure

$17.32

0.01 (0.06%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Downgrade
OraSure rating change  »

OraSure downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

NEP

NextEra Energy Partners

$45.91

-0.51 (-1.10%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Downgrade
NextEra Energy Partners rating change  »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.